Marshall Wace’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1M Sell
1,025,640
-211,644
-17% -$5.18M 0.02% 703
2025
Q4
$33.1M Buy
1,237,284
+363,216
+42% +$9.36M 0.03% 464
2025
Q3
$23.3M Buy
874,068
+25,383
+3% +$655K 0.03% 588
2025
Q2
$19.5M Sell
848,685
-183,037
-18% -$4.54M 0.02% 595
2025
Q1
$29.9M Buy
1,031,722
+423,016
+69% +$13.5M 0.04% 401
2024
Q4
$22.6M Buy
608,706
+40,212
+7% +$1.84M 0.03% 500
2024
Q3
$27.6M Buy
568,494
+341,367
+150% +$15M 0.04% 415
2024
Q2
$9.09M Buy
+227,127
New +$9.41M 0.01% 775
2023
Q2
Sell
-64,209
Closed -$2.41M 2438
2023
Q1
$2.41M Buy
+64,209
New +$2.1M 0.01% 1356
2022
Q4
Sell
-31,638
Closed -$890K 2918
2022
Q3
$890K Buy
31,638
+3,197
+11% +$104K ﹤0.01% 2460
2022
Q2
$989K Buy
28,441
+11,024
+63% +$393K ﹤0.01% 2442
2022
Q1
$625K Buy
+17,417
New +$494K ﹤0.01% 2673
2020
Q3
Sell
-132,228
Closed -$2.97M 1553
2020
Q2
$2.97M Sell
132,228
-169,682
-56% -$3.11M 0.02% 642
2020
Q1
$4.48M Buy
301,910
+7,846
+3% +$137K 0.05% 411
2019
Q4
$5.67M Sell
294,064
-119,229
-29% -$2.29M 0.04% 486
2019
Q3
$8.2M Buy
+413,293
New +$8.61M 0.07% 350

Other funds holding AMPH